M

Matinas BioPharma Holdings Inc
AMEX:MTNB

Watchlist Manager
Matinas BioPharma Holdings Inc
AMEX:MTNB
Watchlist
Price: 1.75 USD 1.16% Market Closed
Market Cap: 8.9m USD

Intrinsic Value

The intrinsic value of one MTNB stock under the Base Case scenario is 14.06 USD. Compared to the current market price of 1.75 USD, Matinas BioPharma Holdings Inc is Undervalued by 88%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MTNB Intrinsic Value
14.06 USD
Undervaluation 88%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Matinas BioPharma Holdings Inc

What is Valuation History?
Compare MTNB to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MTNB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Matinas BioPharma Holdings Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Matinas BioPharma Holdings Inc

Current Assets 8m
Cash & Short-Term Investments 7.3m
Other Current Assets 741k
Non-Current Assets 4.6m
PP&E 2.2m
Intangibles 2.3m
Other Non-Current Assets 200k
Efficiency

Free Cash Flow Analysis
Matinas BioPharma Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Matinas BioPharma Holdings Inc

Revenue
0 USD
Operating Expenses
-20.2m USD
Operating Income
-20.2m USD
Other Expenses
-4.1m USD
Net Income
-24.3m USD
Fundamental Scores

MTNB Profitability Score
Profitability Due Diligence

Matinas BioPharma Holdings Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
19/100
Profitability
Score

Matinas BioPharma Holdings Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

MTNB Solvency Score
Solvency Due Diligence

Matinas BioPharma Holdings Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
62/100
Solvency
Score

Matinas BioPharma Holdings Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MTNB Price Targets Summary
Matinas BioPharma Holdings Inc

There are no price targets for MTNB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Matinas BioPharma Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MTNB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MTNB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MTNB stock?

The intrinsic value of one MTNB stock under the Base Case scenario is 14.06 USD.

Is MTNB stock undervalued or overvalued?

Compared to the current market price of 1.75 USD, Matinas BioPharma Holdings Inc is Undervalued by 88%.

Back to Top